We are developing a rapid, high throughput genetic test to simultaneously assess all known oncogenes and tumor suppressors in Cutaneous T Cell Lymphoma. This test will be useful for diagnosis and staging of patients and should pave the way for tailoring therapeutic strategies for each patient based on molecular data.
|Effective start/end date||3/1/16 → 6/28/17|
- Skin Cancer Foundation (Agreement 1/5/16)
Cutaneous T-Cell Lymphoma